Skip Navigation Links
Listar:
  CódigoNome do ExameSinonimoMetodologiaVolumeMaterialRecipienteTransportePrazoRotinaAlteração recente
Visualizar alteraçõesCISTUCISTINA - QUANTITATIVA - AUTORIZAÇÃO DIRETORIA CEAC E SESCISTINÚRIACROMATOGRAFIA LÍQUIDA - ESPECTROMETRIA DE MASSA (LC-MS/MS)50 mLURINA DE 24 HORASFRASCO URINA 24HSRefrigerado (2 a 8 °C)23 dias uteisSegSIM
Visualizar alteraçõesENDOGENDOMISIO IgG - ANTICORPOS ANTI*IMUNOFLOURESCÊNCIA INDIRETA2 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)13 dias uteisTer,QuiSIM
Visualizar alteraçõesENDOMENDOMISIO IgM - ANTICORPOS ANTI*IMUNOFLOURESCÊNCIA INDIRETA3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)13 dias uteisTer,QuiSIM
Visualizar alteraçõesETANUETANOL SÉRICOÁLCOOL ETÍLICOENZIMÁTICO3 mLSOROSECOCongelado5 dias uteisSeg,Ter,Qua,Qui,SexSIM
Visualizar alteraçõesGADGAD - ANTICORPOS ANTIDESCARBOXILASE DO ÁCIDO GLUTÂMICO, GAD 65, ANTI GAD, KD 64, ELISA3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)11 dias uteisTer,SexSIM
Visualizar alteraçõesHPMHELICOBACTER PYLORI - ANTICORPOS IgM*ELISA3 mLSOROGEL SEPARADORRefrigerado (2 a 8 °C)23 dias uteisSeg,QuiSIM
Visualizar alteraçõesPHpH - DETERMINAÇÃOpHMETRIASEM0.00 mLSEMDIVERSOSRefrigerado (2 a 8 °C)5 dias uteisSeg,Ter,Qua,Qui,SexSIM
Bibliografia :
1. US Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational Exposure to Bloodborne Pathogens.
2. US Department of Health and Human Services. Biosafety in Microbiological and Biomedical Laboratories. 5th ed. Washington, DC: US Government Printing Office; January 2007.
3. World Health Organization. Laboratory Biosafety Manual. Geneva: World Health Organization; 2004.
4. Sewell DL, Bove KE, Callihan DR, et al. Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline- Third Edition (M29-A3). Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
5. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: WB Saunders; 1994:959-60.
6. Tietz NW, editor. Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia, PA: WB Saunders; 1995:268-72.
7. Kaplan LA, Pesce AJ, editors. Clinical Chemistry Theory, Analysis, and Correlation, 3rd ed. St Louis, MO: CV Mosby; 1996:635.
8. Guder WG, Narayanan S, Wisser H, et al. List of analytes-preanalytical variables. Annex In: Samples: From the Patient to the Laboratory. Darmstadt, Germany: GIT Verlag; 1996:Annex 16-7, 38-9, 44-5.
9. US Pharmacopeial Convention, Inc. General notices. In: US Pharmacopeia National Formulary, 1995 ed (USP 23/NF 18). Rockville, MD: The US Pharmacopeial Convention, Inc; 1994:11. 10. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2007;30(1):42-7.
11. Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002;48(3):436-72.
12. Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry, 2nd ed. Philadelphia, PA: WB Saunders; 1994:2190.
13. Young DS. Effects of Drugs on Clinical Laboratory Tests, 4th ed. Washington, DC: AACC Press; 1995:3-274-3-294.
14. Kennedy JW, Carey RN, Coolen RB, et al. Evaluation of Precision Performance of Clinical Chemistry Devices; Approved Guideline (EP5- A). Wayne, PA: The National Committee for Clinical Laboratory Standards, 1999.
15. Krouwer JS, Tholen DW, Garber CC, et al. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline-Second Edition (EP9-A2). Wayne, PA: The National Committee for Clinical Laboratory Standards, 2002.
16.John Bernard Henry,M.D Diagnósticos Clínicos e Tratamento por Métodos Laboratoriais.
17.Sociedade Brasileira de Patologia Clínica / Medicina Laboatorial. (2ª edição).